Drug Therapy, Combination
"Drug Therapy, Combination" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Therapy with two or more separate preparations given for a combined effect.
| Descriptor ID |
D004359
|
| MeSH Number(s) |
E02.319.310
|
| Concept/Terms |
Drug Therapy, Combination- Drug Therapy, Combination
- Combination Chemotherapy
- Drug Polytherapy
- Drug Polytherapies
- Polytherapies, Drug
- Polytherapy, Drug
- Therapy, Combination Drug
- Chemotherapy, Combination
- Chemotherapies, Combination
- Combination Chemotherapies
- Combination Drug Therapy
- Combination Drug Therapies
- Drug Therapies, Combination
- Therapies, Combination Drug
|
Below are MeSH descriptors whose meaning is more general than "Drug Therapy, Combination".
Below are MeSH descriptors whose meaning is more specific than "Drug Therapy, Combination".
This graph shows the total number of publications written about "Drug Therapy, Combination" by people in this website by year, and whether "Drug Therapy, Combination" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 22 | 24 |
| 1997 | 0 | 15 | 15 |
| 1998 | 0 | 13 | 13 |
| 1999 | 0 | 21 | 21 |
| 2000 | 1 | 8 | 9 |
| 2001 | 0 | 16 | 16 |
| 2002 | 0 | 20 | 20 |
| 2003 | 0 | 24 | 24 |
| 2004 | 1 | 16 | 17 |
| 2005 | 0 | 23 | 23 |
| 2006 | 0 | 20 | 20 |
| 2007 | 0 | 26 | 26 |
| 2008 | 1 | 28 | 29 |
| 2009 | 1 | 26 | 27 |
| 2010 | 0 | 29 | 29 |
| 2011 | 0 | 23 | 23 |
| 2012 | 2 | 11 | 13 |
| 2013 | 1 | 28 | 29 |
| 2014 | 1 | 21 | 22 |
| 2015 | 0 | 22 | 22 |
| 2016 | 0 | 16 | 16 |
| 2017 | 0 | 16 | 16 |
| 2018 | 2 | 21 | 23 |
| 2019 | 0 | 24 | 24 |
| 2020 | 2 | 16 | 18 |
| 2021 | 1 | 16 | 17 |
| 2022 | 0 | 10 | 10 |
| 2023 | 0 | 7 | 7 |
| 2024 | 1 | 7 | 8 |
| 2025 | 0 | 16 | 16 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Therapy, Combination" by people in Profiles.
-
Comparing Outcomes With Subcutaneous Infliximab (CT-P13 SC) by Baseline Immunosuppressant Use: A Post Hoc Analysis of the LIBERTY-CD and LIBERTY-UC Studies. Inflamm Bowel Dis. 2025 Oct 01; 31(10):2714-2724.
-
Triple therapy vs dual inhaler therapy for moderate-to-severe asthma: An updated systematic review and meta-analysis. Ann Allergy Asthma Immunol. 2025 Sep; 135(3):278-286.e11.
-
Therapeutic Choices in Systemic Sclerosis-Associated Interstitial Lung Disease, a Survey of 2 International Research Groups. J Clin Rheumatol. 2025 Oct 01; 31(7):284-287.
-
Fixed-dose combination of obicetrapib and ezetimibe for LDL cholesterol reduction (TANDEM): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet. 2025 05 17; 405(10491):1757-1768.
-
Efficacy and safety of relugolix combination therapy in women with uterine fibroids and adenomyosis: subgroup analysis of LIBERTY 1 and LIBERTY 2. Fertil Steril. 2025 Sep; 124(3):523-533.
-
Impact of Batoclimab Treatment on LDL-C with and Without Coadministration of Atorvastatin: Results from a Phase I Randomized Study in Healthy Participants. Drug Saf. 2025 Sep; 48(9):993-1004.
-
GLP-1 RA and dual GIP/GLP-1 RA treatment in MODY: a descriptive case series. BMJ Open Diabetes Res Care. 2025 Apr 23; 13(2).
-
Shared Decisionmaking in the Treatment of Hypothyroidism. Clin Endocrinol (Oxf). 2025 Jul; 103(1):106-112.
-
Real-world experience of cannabidiol in conjunction with clobazam for the treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome: Results from a retrospective multicentre chart review in Germany. Epilepsy Behav. 2025 May; 166:110302.
-
Etrasimod Corticosteroid-Free Efficacy, Impact of Concomitant Corticosteroids on Efficacy and Safety, and Corticosteroid-Sparing Effect in Ulcerative Colitis: Analyses of the ELEVATE UC Clinical Program. J Crohns Colitis. 2025 Mar 05; 19(3).